Arihant Kumar Singh

About

A trained researcher on nanofomulation development use as carrier or imaging tool for small and large molecules and labelling immune cells and exosomes for in-vivo imaging. Expertise in biomaterials synthesis, analytical characterization & drug delivery system by translating research into scalable, application-oriented solutions through strong experimental design and cross-functional collaboration. Committed to advancing innovative, interdisciplinary research and industry based therapeutics.

Employment

• The University of Texas MD Anderson Cancer Center Postdoctoral Fellow
  2025 - Present
• Michigan State University PostDoc Research Associate
  2024 - 2025
• Apeejay Stya University Assistant Professor
  2024 - 2024
• Birla Institute of Technology & Science Pilani Ph.D. Student
  2018 - 2024
• Sristi Organization Research Associate
  2014 - 2015

Education

• Birla Institute of Technology and Science, Pilani Ph.D.
  2018 - 2024
• Maharashtra Institute of Pharmacy M. Pharm.
  2015 - 2017
• Gujarat Technological University B. Pharm.
  2010 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Formulation of Peptide Nano-Complexes for Delivery of Peptide and Method of Preparation
  Indian Patent 2025
  +Save
• Potent anti-inflammatory and anti-apoptotic activities of electrostatically complexed C-peptide nanospheres ameliorate diabetic nephropathy
  Biomaterials Advances 2024 DOI: 10.1016/j.bioadv.2024.213935
  +Save
• Restoring physiological parameters of the pancreas and kidney through treatment with a polymeric nano-formulation of C-peptide and lisofylline combination in diabetic nephropathy
  Nanoscale 2024 DOI: 10.1039/D4NR02010C
  +Save
• Belinostat loaded lipid–polymer hybrid nanoparticulate delivery system for breast cancer: improved pharmacokinetics and biodistribution in a tumor model
  Journal of Materials Chemistry B 2023 DOI: 10.1039/d3tb01317k
  +Save
• Enhanced anti-tumor efficacy and tumor accumulation of Tamoxifen through cRGD functionalized cholesterol based lipopolymeric nanoparticles for targeted breast cancer therapy
  Journal of Drug Delivery Science and Technology 2023 DOI: 10.1016/j.jddst.2023.105173
  +Save
• An Apparatus And A Method For Tracking Laboratory Animals
  Indian Patent 2022
  +Save
• Influence of Fatty Acid Structure on the Behavior of Drug–Fatty Acid Conjugates for Diabetes Treatment
  6th Bioengineering & Translational Medicine Conference 2021
  +Save
• Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat
  AAPS PharmSciTech 2021 DOI: 10.1208/s12249-021-01980-5
  +Save
• Role of Chain Length and Degree of Unsaturation of Fatty Acids in the Physicochemical and Pharmacological Behavior of Drug-Fatty Acid Conjugates in Diabetes
  Journal of Medicinal Chemistry 2021 DOI: 10.1021/acs.jmedchem.1c00391
  +Save
• Therapeutic agents for targeting desmoplasia: current status and emerging trends
  Drug Discovery Today 2020 DOI: 10.1016/j.drudis.2020.09.008
  +Save